Skip to main content
. 2023 Mar 2;55(3):484–495. doi: 10.1038/s41588-023-01324-y

Extended Data Fig. 3. CasRx-mediated MERVL-KD and its effects on preimplantation development.

Extended Data Fig. 3

(a) Schematic of experimental procedure for CasRx-mediated KD of MERVL. (b) Representative images of smFISH and immunofluorescence staining for MERVL RNA (top) and MERVL-Gag protein (bottom) with DAPI counterstain in untargeted control and MERVL-KD two-cell stage embryos at 1.5 dpc, from 3 independent experiments. Scale bar: 20 µm. (c) Representative phase-contrast images of 4.5 dpc blastocysts upon untargeted control and MERVL-KD conditions, from 3 independent experiments. Scale bar: 100 µm. (d) Percentage of embryos by stages of development, upon untargeted control (n = 69) and MERVL-KD (n = 70) conditions. N.S., not significant; ***P < 0.001, chi-square test. Data for panel in d is available as source data.

Source data